These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 26507430)
1. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase. Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase. Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964 [TBL] [Abstract][Full Text] [Related]
3. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility. Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase. Kim IH; Park YK; Hammock BD; Nishi K J Med Chem; 2011 Mar; 54(6):1752-61. PubMed ID: 21338111 [TBL] [Abstract][Full Text] [Related]
5. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors. Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315 [TBL] [Abstract][Full Text] [Related]
7. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase. Anandan SK; Webb HK; Do ZN; Gless RD Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA. Karami L; Saboury AA; Rezaee E; Tabatabai SA Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588 [TBL] [Abstract][Full Text] [Related]
9. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility. Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649 [TBL] [Abstract][Full Text] [Related]
10. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors. Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357 [TBL] [Abstract][Full Text] [Related]
11. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors. Rezaee E; Amrolah SM; Nazari M; Tabatabai SA Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869 [TBL] [Abstract][Full Text] [Related]